Ledger.Open graph →
SEC Form D · filed December 30, 2016

Imprimis Pharmaceuticals, Inc

Offering
$10.1M
Sold
$10.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Mark Baum · San Diego, CAExec · DirectorAndrew Boll · San Diego, CAExecAnthony Principi · San Diego, CADirectorSteve Delin · Roanoke, TXExec · DirectorJames Works · Roanoke, TXExecRobert Kammer · Solana Beach, CADirectorRichard Lindstrom · Waltham, MADirectorStephen Austin · Calgary, Alberta, CanadaDirectorPreetish Nijhawan · PALO ALTO, CAExecPeter Mills · St Peter Port, Y7Exec · DirectorRobert Kammer · Oceanside, CADirectorAnthony Principi · San Diego, CADirectorRichard Lindstrom · San Diego, CADirectorStephen Austin · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗